Content
Regrow hair in as few as 3-6 months
The oral medication finasteride (brand name Propecia®) is one of two FDA-approved medications for the treatment of androgenic alopecia.
Because oral finasteride has known sexual side effects (like erectile dysfunction and decreased libido) some men feel that using a topical finasteride treatment could be a preferable alternative.
Topical finasteride has yet to receive FDA approval, and there’s very limited research on how it works and its benefits. That all leads to some pressing questions: Does topical finasteride have side effects? And perhaps more importantly, is topical finasteride safe?
Below, we’ve discussed the side effects of this treatment, and effective treatment alternatives if you’re not sure it’s right for you.
Content
Every medication can have potential side effects. If you’ve ever looked up finasteride side effects, you may have seen common adverse effects like sexual dysfunction, reduced ejaculation or even insomnia from finasteride. However, these are most often from oral finasteride. Topical finasteride is more likely to cause irritation to the skin at the point of application.
Finasteride belongs to a group of medications called 5-alpha reductase inhibitors. These medications prevent the conversion of testosterone to dihydrotestosterone, which can prevent further hair loss.
The most common form of hair loss, male pattern baldness (also called androgenetic alopecia or AGA) affects up to 50 percent of men by age 50. High DHT levels cause the hair follicles — the tiny organs throughout your scalp from which your hair grows — to shrink, leading to baldness.
The receding hairline or thinning hair that signals hair loss is caused by enzymes that convert testosterone into the male sex hormone dihydrotestosterone (DHT), a major androgen.
Finasteride can stop this, though it does include side effect risks.
While oral finasteride takes effect through systemic absorption (absorption by every part of the body — skin, hair, liver, etc.), the topical formulation provides localized treatment, just on your scalp.
That means the side effects will typically be topical too. And depending on the topical format, they can vary slightly.
A clinical study that compared the effects of oral finasteride against a finasteride 0.25% topical solution was carried out on 24 men with androgenetic alopecia.
The men from the clinical trial who applied the topical finasteride solution to their scalps for one week showed similar results to those who took 1mg of oral finasteride for the same amount of time. Specifically, scalp DHT was reduced by 68 to 75 percent when topical finasteride was used, compared to 62 to 72 percent with the oral tablet. Researchers also found that the topical solution was well-tolerated.
Another study in the Indian Journal of Dermatology comparing the effects of topical finasteride gel to the oral tablet form was carried out on 45 male androgenetic alopecia patients. The patients used the gel twice a day for six months, while the finasteride tablets were used once a day.
By the end of the study, both groups saw similar positive effects on hair growth.
A study of more than 440 patients that looked at the effectiveness of a topical finasteride spray compared to the oral tablet found that the spray significantly improved hair count compared to placebo, but had less of an impact on serum DHT levels than the oral version.
While all these studies show promising results for the effectiveness of topical finasteride, many are too small to gauge if a finasteride spray can really encourage hair regrowth.
But what about topical finasteride spray side effects or adverse effects of a finasteride gel?
Topical finasteride, like all medications, can lead to some side effects. But many of these studies reported that the hair loss treatment was well-tolerated, with a few minor side effects, including:
Lightheadedness
Headaches
Redness at application site
Scalp itching
Irritation
Although much rarer, serious side effects are possible. For example, two subjects in the first study reported increased levels of alanine transaminase — a dangerous situation for the liver with high, frequent daytime urination and testicular pain.
And while we can appreciate a moment of craftiness, we have to urge that you don't make your own topical finasteride.
Men and women frustrated with hair loss have an abundance of hair restoration options available, from hair transplants and laser treatments, to other medications. Some may wonder if topical finasteride is safe when used with other hair loss treatments. The short answer is yes, sometimes. But you should seek medical advice for the treatment of androgenetic alopecia before combining any treatments on your own.
One of the safest options generally is Minoxidil — the other medication approved by the FDA for male pattern hair loss.
Minoxidil, a topical solution, stimulates hair growth by encouraging blood flow to your hair follicles. It’s also thought that minoxidil lengthens the growth phase of your natural hair growth cycle.
In a study testing the effectiveness of a treatment that combined topical finasteride, dutasteride (another 5-alpha reductase inhibitor) and topical minoxidil, 15 male patients applied a mix of these products for nine months.
Those who used the topical finasteride treatment, dutasteride and minoxidil solution saw hair growth after three months. This combination was well-tolerated, even in patients with a tendency for allergies.
While FDA-approved to treat male hair loss, oral finasteride can cause side effects like sexual dysfunction. Therefore, some may opt for a topical finasteride treatment option to reduce the risk of those systemic side effects.
But is topical finasteride safe, and what side effects can you expect? Here’s what you need to know.
Finasteride works to block the conversion of testosterone into the hormone dihydrotestosterone (DHT), which causes male pattern baldness. While often prescribed as an oral tablet, topical finasteride solutions are available (but not FDA-approved).
While there haven’t been any large studies of the effects of topical finasteride, multiple smaller studies have shown that it significantly improved hair count and hair density, with lower risk of side effects.
There can be some side effects of topical finasteride though, including irritation, an itching or burning sensation, lightheadedness, or redness where the solution is applied.
You can learn more about topical finasteride use, from how to apply it to safety measures, in our full guide. We’ve also covered the effectiveness of topical finasteride and gone more in-depth on the side effects of oral finasteride.
If you want to explore more hair loss treatments, start by connecting with a dermatologist or healthcare provider today.
If you’re looking for a combination solution to treat hair loss, we offer a topical finasteride & minoxidil spray.
Or you can try minoxidil on its own, available as either a minoxidil foam or liquid minoxidil solution drops, both of which are applied directly to the scalp.
If you’re looking for more ways to encourage hair growth or boost thin hair, adding supplements like biotin gummies can lead to a fuller head of hair.
You can also try hair products like a thickening shampoo with saw palmetto or this volumizing shampoo and conditioner duo for thinning hair to give your locks some lift.
Hims & Hers has strict sourcing guidelines to ensure our content is accurate and current. We rely on peer-reviewed studies, academic research institutions, and medical associations. We strive to use primary sources and refrain from using tertiary references. See a mistake? Let us know at [email protected]!
Dr. Knox Beasley is a board certified dermatologist specializing in hair loss. He completed his undergraduate studies at the United States Military Academy at West Point, NY, and subsequently attended medical school at Tulane University School of Medicine in New Orleans, LA.
Dr. Beasley first began doing telemedicine during his dermatology residency in 2013 with the military, helping to diagnose dermatologic conditions in soldiers all over the world.
Dr. Beasley is board certified by the American Board of Dermatology, and is a Fellow of the American Academy of Dermatology.
Originally from Nashville, TN, Dr. Beasley currently lives in North Carolina and enjoys spending time outdoors (with sunscreen of course) with his wife and two children in his spare time.
Bachelor of Science, Life Sciences. United States Military Academy.
Doctor of Medicine. Tulane University School of Medicine
Dermatology Residency. San Antonio Uniformed Services Health Education Consortium
Board Certified. American Board of Dermatology
Wilson, L. M., Beasley, K. J., Sorrells, T. C., & Johnson, V. V. (2017). Congenital neurocristic cutaneous hamartoma with poliosis: A case report. Journal of cutaneous pathology, 44(11), 974–977. https://onlinelibrary.wiley.com/doi/10.1111/cup.13027
Banta, J., Beasley, K., Kobayashi, T., & Rohena, L. (2016). Encephalocraniocutaneous lipomatosis (Haberland syndrome): A mild case with bilateral cutaneous and ocular involvement. JAAD case reports, 2(2), 150–152. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4867906/
Patterson, A. T., Beasley, K. J., & Kobayashi, T. T. (2016). Fibroelastolytic papulosis: histopathologic confirmation of disease spectrum variants in a single case. Journal of cutaneous pathology, 43(2), 142–147. https://onlinelibrary.wiley.com/doi/10.1111/cup.12569
Beasley, K., Panach, K., & Dominguez, A. R. (2016). Disseminated Candida tropicalis presenting with Ecthyma-Gangrenosum-like Lesions. Dermatology online journal, 22(1), 13030/qt7vg4n68j. https://pubmed.ncbi.nlm.nih.gov/26990472/
Kimes, K., Beasley, K., & Dalton, S. R. (2015). Eruptive milia and comedones during treatment with dovitinib. Dermatology online journal, 21(9), 13030/qt8kw141mb. https://pubmed.ncbi.nlm.nih.gov/26437285/
Miladi, A., Thomas, B. C., Beasley, K., & Meyerle, J. (2015). Angioimmunoblastic t-cell lymphoma presenting as purpura fulminans. Cutis, 95(2), 113–115. https://pubmed.ncbi.nlm.nih.gov/25750965/
Beasley K, Dai JM, Brown P, Lenz B, Hivnor CM. (2013). Ablative Fractional Versus Nonablative Fractional Lasers – Where Are We and How Do We Compare Differing Products?. Curr Dermatol Rep, 2, 135–143. https://idp.springer.com/authorize?response_type=cookie&client_id=springerlink&redirect_uri=https%3A%2F%2Flink.springer.com%2Farticle%2F10.1007%2Fs13671-013-0043-0
Siami P, Beasley K, Woolen S, Zahn J. (2012). A retrospective study evaluating the efficacy and tolerability of intra-abdominal once-yearly histrelin acetate subcutaneous implant in patients with advanced prostate cancer. UroToday Int J, June 5(3), art 26. https://www.urotoday.com/volume-5-2012/vol-5-issue-3/51132-a-retrospective-study-evaluating-the-efficacy-and-tolerability-of-intra-abdominal-once-yearly-histrelin-acetate-subcutaneous-implants-in-patients-with-advanced-prostate-cancer.html
Siami P, Beasley K. (2012). Dutasteride with As-Needed Tamsulosin in Men at Risk of Benign Prostate Hypertrophy Progression. UroToday Int J, Feb 5(1), art 93. https://www.urotoday.com/volume-5-2012/vol-5-issue-1/48691-dutasteride-with-as-needed-tamsulosin-in-men-at-risk-of-benign-prostatic-hypertrophy-progression.html